Clinical Trial Update: Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ABP-745 for efficacy, safety, and population pharmacokinetics in patients with atherosclerosis and ASCVD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• ABP-745

Snippet

Sponsor: Atom Therapeutics Co., Ltd | Conditions: Atherosclerosis Cardiovascular Disease, ASCVD | Phase 2 | Status: NOT_YET_RECRUITING